Clinical Trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected viruses.

Fiche publication

Date publication

mai 2025

Journal

The Journal of infection

Auteurs

Membres identifiés du Cancéropôle Est :
Dr VERRIER Eloi

Tous les auteurs :
Delphin M, Campbell J, Verrier ER, Anderson M, Sukali G, Maponga T, Stockdale A, Matthews PC

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40409503

Résumé

We set out to evaluate the extent to which Hepatitis Delta Virus (HDV) Clinical Trials (CT) include populations from the World Health Organisation (WHO) African region, aiming to highlight inequities and advocate for global investment in inclusive HDV research.